Success Metrics

Clinical Success Rate
97.8%

Based on 44 completed trials

Completion Rate
98%(44/45)
Active Trials
1(2%)
Results Posted
16%(7 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_4
1
2%
Ph not_applicable
3
6%
Ph phase_3
1
2%
Ph phase_1
41
87%
Ph phase_2
1
2%

Phase Distribution

41

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution47 total trials
Phase 1Safety & dosage
41(87.2%)
Phase 2Efficacy & side effects
1(2.1%)
Phase 3Large-scale testing
1(2.1%)
Phase 4Post-market surveillance
1(2.1%)
N/ANon-phased studies
3(6.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.7%

44 of 46 finished

Non-Completion Rate

4.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

47

all time

Status Distribution
Active(1)
Completed(44)
Terminated(2)

Detailed Status

Completed44
Terminated1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
47
Active
1
Success Rate
97.8%
Most Advanced
Phase 4

Trials by Phase

Phase 141 (87.2%)
Phase 21 (2.1%)
Phase 31 (2.1%)
Phase 41 (2.1%)
N/A3 (6.4%)

Trials by Status

terminated12%
recruiting12%
withdrawn12%
completed4494%

Recent Activity

Clinical Trials (47)

Showing 20 of 47 trialsScroll for more
NCT07229404Phase 1

A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants

Completed
NCT07214922Phase 1

Relative Bioavailability of Evobrutinib Tablet Batches

Completed
NCT06453265Phase 1

A Study to Assess the Abuse Potential of Intranasal Cebranopadol

Completed
NCT01730560Not Applicable

Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach

Completed
NCT07162441Phase 1

A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

Recruiting
NCT06661694Phase 1

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Withdrawn
NCT05578846Phase 1

Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics

Completed
NCT06693518Phase 1

A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults

Completed
NCT04489134Phase 2

P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release

Completed
NCT05122143Not Applicable

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Completed
NCT05868356Phase 1

A PK Study to Assess the Drug-drug Interaction of a Strong CYP2C8 Inhibitor on Adagrasib

Completed
NCT02808455Phase 1

Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects

Completed
NCT04600505Phase 1

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Completed
NCT05195892Phase 1

Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers

Completed
NCT05463497Phase 1

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

Completed
NCT04049175Phase 3

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

Terminated
NCT04798222Phase 1

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Completed
NCT04970940Phase 1

The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

Completed
NCT03804645Phase 1

A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Completed
NCT00902512Phase 4

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Completed

Drug Details

Intervention Type
DRUG
Total Trials
47